Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Malignancy, mortality, and morbidity: Autoimmune encephalitis in the ICU | Synapse
March 3, 2026
Malignancy, mortality, and morbidity: Autoimmune encephalitis in the ICU
KT
Kevin Soon Hwee Teo
CT
Christopher Thong
National University Hospital
YG
Yihui Goh
National University of Singapore
Ver todo
Puntos clave
High mortality rates are associated with autoimmune encephalitis in ICU patients, indicating severe illness.
Survival analysis shows that malignancy significantly impacts patient outcomes, with poorer survival rates observed.
Assessment of clinical outcomes reveals substantial morbidity among those treated for autoimmune encephalitis in ICU settings.
The findings emphasize the need for early detection and treatment of autoimmune conditions to improve outcomes.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Teo et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75f71c6e9836116a2ad19
https://doi.org/https://doi.org/10.1016/j.jns.2025.124567